Journal
JOURNAL OF IMMUNOLOGY
Volume 171, Issue 11, Pages 5997-6005Publisher
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.171.11.5997
Keywords
-
Categories
Funding
- NATIONAL CANCER INSTITUTE [R01CA081383] Funding Source: NIH RePORTER
- NCI NIH HHS [CA81383-04] Funding Source: Medline
Ask authors/readers for more resources
Tumor necrosis factor receptor-associated factor 2 (TRAF2), an adapter protein that associates with the cytoplasmic tail of OX40, may play a critical role in OX40-mediated signal transduction. To investigate the in vivo role of TRAF2 in OX40-mediated generation of Ag-specific memory T cells, we bred OVA-specific TCR transgenic mice to TRAF2 dominant-negative (TRAF2 DN) mice. Following Ag stimulation and OX40 engagement of TRAF2 DN T cells in vivo, the number of long-lived OVA-specific T cells and effector T cell function was dramatically reduced when compared with wild-type T cells. We also demonstrate that CTLA-4 is down-regulated following OX40 engagement in vivo and the OX40-specific TRAF2 DN defect was partially overcome by CTLA-4 blockade in vivo. The data provide evidence that TRAF2 is linked to OX40-mediated memory T cell expansion and survival, and point to the down-regulation of CTLA-4 as a possible control element to enhance early T cell expansion through OX40 signaling.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available